Pedro P Guerra Selected Research

Gangliosides

7/2014

A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro P Guerra Research Topics

Disease

2	Neoplasms (Cancer) 01/2023 - 07/2014
1	Adenocarcinoma 01/2023
1	Pain (Aches) 07/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014
1	Asthenia 07/2014

Drug/Important Bio-Agent (IBA)

1	nimotuzumabIBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	VaccinesIBA 07/2014
1	aluminum sulfate (alum)IBA 07/2014
1	racotumomabIBA 07/2014
1	GangliosidesIBA 07/2014

Therapy/Procedure

1	Therapeutics 07/2014